Field safety notices: Devyser
Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.
1 authority publication by one authority, from 7 Mar 2025 to 7 Mar 2025.
Latest notice: 7 Mar 2025, AEMPS, Kit de reactivos:
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Devyser or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
1 distinct corrective action.
- Kit de reactivos:Models, lots, UDI: - Devyser BRCA, lote 24J211, UDI-DI 07350040631775 ; - Devyser CFTR, lote 24F999, UDI-DI 07350040631805 ; - Devyser HBOC, lote 24B338, UDI-DI 07350040631638 ; - Devyser Talasemia, lote 24L554, UDI-DI 07350040631591
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026